Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material.
Apr 2, 2010
By: Phil Borman, Marion Chatfield, Patrick Jackson, Alice Laures, George Okafo
Pharmaceutical Technology
Volume 34, Issue 4, pp. 72-86

Please refer to the full online version of this article, located here.

ADVERTISEMENT

blog comments powered by Disqus
About the Author

Phil Borman


Phil Borman, is a manager in Analytical Sciences, chemical development, at GlaxoSmithKline in the UK. Articles by Phil Borman

Marion Chatfield

Marion Chatfield is a manager in Statistical Sciences at GlaxoSmithKline (Hertfordshire). Articles by Marion Chatfield

Patrick Jackson

Patrick Johnson is an analytical chemist in analytical sciences/chemical development at GlaxoSmithKline in the UK. Articles by Patrick Jackson

Alice Laures

Alice Laures is an analytical chemist in analytical sciences/chemical development at GlaxoSmithKline in the UK. Articles by Alice Laures

George Okafo

George Okafo is a manager in Scinovo, Preclinical Development at GlaxoSmithKline (UK). Articles by George Okafo
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Featured Jobs

More Jobs
Source: Pharmaceutical Technology, 4/2/2010
 Click here